|
Aug 6
|
Pacira BioSciences Inc (PCRX) Q2 2025 Earnings Call Highlights: Strong Growth in EXPAREL Sales ...
|
|
Aug 6
|
Here's What Key Metrics Tell Us About Pacira (PCRX) Q2 Earnings
|
|
Aug 5
|
Pacira (PCRX) Tops Q2 Earnings Estimates
|
|
Aug 5
|
Pacira: Q2 Earnings Snapshot
|
|
Aug 5
|
Pacira BioSciences Reports Second Quarter 2025 Financial Results
|
|
Jul 31
|
PharmaCorp Announces Filing of Annual Information Form
|
|
Jul 24
|
Pacira to Report Second Quarter 2025 Financial Results on Tuesday August 5, 2025
|
|
Jul 22
|
Pacira BioSciences Announces Strategic Collaboration to Significantly Expand ZILRETTA Promotional Efforts
|
|
Jun 11
|
Pacira BioSciences Unveils Three-Year Clinical Data Following a Single Local Administration of Investigational Gene Therapy, PCRX-201, in Patients with Moderate-to-Severe Osteoarthritis of the Knee
|
|
May 22
|
Pacira BioSciences (NASDAQ:PCRX) adds US$78m to market cap in the past 7 days, though investors from three years ago are still down 57%
|
|
Mar 2
|
Is Pacira BioSciences, Inc. (PCRX) the Best Small Cap Pharma Stock to Buy Now?
|
|
Mar 2
|
Earnings Update: Here's Why Analysts Just Lifted Their Pacira BioSciences, Inc. (NASDAQ:PCRX) Price Target To US$31.71
|
|
Feb 28
|
Q4 2024 Pacira Biosciences Inc Earnings Call
|
|
Feb 28
|
Pacira BioSciences Inc (PCRX) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic ...
|
|
Feb 27
|
Pacira: Q4 Earnings Snapshot
|
|
Feb 27
|
Pacira BioSciences Reports Fourth Quarter and Full-Year 2024 Financial Results
|
|
Feb 27
|
Pacira BioSciences Acquires Remaining Equity Stake of GQ Bio
|
|
Feb 26
|
Pacira BioSciences to Participate in Fireside Chat at Two Healthcare Conferences in March
|
|
Feb 20
|
Why Pacira (PCRX) is a Top Momentum Stock for the Long-Term
|
|
Feb 20
|
Pacira to Report 2024 Financial Results on Thursday February 27, 2025
|